PharmaTher PHRRF Stock
PharmaTher Price Chart
PharmaTher PHRRF Financial and Trading Overview
PharmaTher stock price | 0.13 USD |
Previous Close | 0.08 USD |
Open | 0.07 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.06 - 0.07 USD |
52 Week Range | 0.04 - 0.16 USD |
Volume | 29.19K USD |
Avg. Volume | 73.45K USD |
Market Cap | 6.04M USD |
Beta (5Y Monthly) | 2.782272 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.04 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PHRRF Valuation Measures
Enterprise Value | -840806 USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.85625 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | 0.196 |
Trading Information
PharmaTher Stock Price History
Beta (5Y Monthly) | 2.782272 |
52-Week Change | -43.90% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.16 USD |
52 Week Low | 0.04 USD |
50-Day Moving Average | 0.09 USD |
200-Day Moving Average | 0.09 USD |
PHRRF Share Statistics
Avg. Volume (3 month) | 73.45K USD |
Avg. Daily Volume (10-Days) | 95.3K USD |
Shares Outstanding | 88.17M |
Float | 71.05M |
Short Ratio | N/A |
% Held by Insiders | 18.67% |
% Held by Institutions | 0.056% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | May 31, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | May 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -27.52% |
Return on Equity (ttm) | -51.43% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -4280054 USD |
Net Income Avi to Common (ttm) | -4761034 USD |
Diluted EPS (ttm) | -0.04 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 7.5M USD |
Total Cash Per Share (mrq) | 0.09 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 13.446 |
Book Value Per Share (mrq) | 0.08 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3595301 USD |
Levered Free Cash Flow (ttm) | -2124912 USD |
Profile of PharmaTher
Country | United States |
State | ON |
City | Toronto |
Address | 82 Richmond Street East |
ZIP | M5C 1P1 |
Phone | 888 846 3171 |
Website | https://www.pharmather.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications. Its pipeline also comprises Ketamine Patch that is in Phase I and II clinical trials for treating depression, mental health, complex regional pain syndrome, and pain disorders; and Ketamine Pump, which is in Phase II clinical trial to treat metal health, pain disorders, and surgery/procedure. In addition, the company engages in the development of PHARMAPATCH, a microneedle patch to deliver psychedelics. It has collaboration agreements with LTS Lohmann Therapie-Systeme AG for developing Ketamin microneedle patch; Alcami Corporation to develop Ketamin injectables/infusions; BioRAE, Inc. for the development of Ketamin pumps; Revive Therapeutics Ltd. to develop psilocybin microneedle patch; Gesval S.A. for the development of patented continuous-flow process technology for the preparation of ketamine and ketamine analogs; and PharmaTher's to create a proprietary wearable ketamine delivery solution for mental health, neurological and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Q&A For PharmaTher Stock
What is a current PHRRF stock price?
PharmaTher PHRRF stock price today per share is 0.13 USD.
How to purchase PharmaTher stock?
You can buy PHRRF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaTher?
The stock symbol or ticker of PharmaTher is PHRRF.
Which industry does the PharmaTher company belong to?
The PharmaTher industry is Biotechnology.
How many shares does PharmaTher have in circulation?
The max supply of PharmaTher shares is 88.52M.
What is PharmaTher Price to Earnings Ratio (PE Ratio)?
PharmaTher PE Ratio is now.
What was PharmaTher earnings per share over the trailing 12 months (TTM)?
PharmaTher EPS is -0.04 USD over the trailing 12 months.
Which sector does the PharmaTher company belong to?
The PharmaTher sector is Healthcare.